Alison A McCormick

Off-the-shelf adenoviral-mediated immunotherapy via bicistronic expression of tumor antigen and iMyD88/CD40 adjuvant.

J. Levitt, A. McCormick, D. Spencer, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig.

R. Levy, A. McCormick, F. Vojdani, 2003, Journal of immunological methods.

Activity of and Effect of Subcutaneous Treatment with the Broad-Spectrum Antiviral Lectin Griffithsin in Two Laboratory Rodent Models

D. Montefiori, K. Palmer, G. Brock, 2013, Antimicrobial Agents and Chemotherapy.

TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.

K. Palmer, G. Pogue, A. McCormick, 2006, Vaccine.

Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System

A. McCormick, C. Bakshi, M. Malik, 2015, PloS one.

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.

K. Palmer, J. Lindbo, A. McCormick, 2006, Virology.

Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge

H. Kaur, A. McCormick, C. Bakshi, 2018, PloS one.

An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia

H. Kaur, A. McCormick, C. Bakshi, 2018, Front. Microbiol..